Viatris Director Acquires 24,835 Shares via Award Vesting
Viatris Inc
Subscribe to track VTRS
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Viatris Director Acquires 24,835 Shares via Award Vesting
Company: Viatris Inc (VTRS) Form: 4 | Filed: 2026-03-10 Significance: Low
Insider: Mark W Parrish Title: Director | Relationship: Director
Transaction: • Type: Exercise/Vesting • Shares: 24,835 • Price: $0.00 • Value: $0.00 • Owned After: 165,230
Key Insight: Routine compensation event involving the vesting of previously granted RSUs and Dividend Equivalents, plus a new grant of 15,890 RSUs.
Market Context: Transaction represents negligible volume (0.002% of outstanding shares) relative to the company's $17.19B market cap.
Comprehensive Analysis
SEC Filing Analysis: Viatris Inc (VTRS)
Executive Summary
- Trading Significance: Low
- Key Takeaway: Routine director compensation involving RSU vesting and new grants; no open market activity.
- Market Impact: Neutral - This is a standard administrative filing regarding remuneration.
Company Information
| Field | Value |
|---|---|
| Company | Viatris Inc |
| Ticker Symbol | VTRS |
| CIK | 0001792044 |
| Industry | Pharmaceutical Preparations |
Insider Information
| Field | Value |
|---|---|
| Name | Mark W Parrish |
| CIK | 0001236452 |
| Title/Position | Director |
| Relationship | Director |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2026-03-06 |
| Transaction Code | M (Exercise/Conversion) |
| Security Type | Common Stock |
| Shares Involved | 24,835 |
| Price Per Share | $0.00 |
| Total Value | $0.00 |
| Shares Owned After | 165,230 |
| Ownership Type | Direct |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $0.00 (Compensation) |
| % of Market Cap | 0.00% |
| Shares Transacted | 24,835 |
| % of Shares Outstanding | 0.002% |
| Post-Transaction Ownership | 165,230 shares (0.014% of outstanding) |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: Viatris is a Large Cap company ($17.19B). This transaction is purely administrative compensation and holds no monetary weight against the market cap.
- Ownership Concentration: The insider holds a very small fraction of the 1.15 billion shares outstanding.
- Dilution Impact: The filing includes a new grant of 15,890 RSUs (vesting in 2027). This represents ~0.001% potential dilution, which is negligible.
- Transaction Significance: The transaction volume is well below the 0.1% threshold required for moderate significance.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: This filing documents the vesting of restricted stock units and dividend equivalents, along with a new annual grant. It does not reflect a change in the insider's sentiment toward the stock price.
Volume & Sentiment
- Expected Volume Impact: None.
- Sentiment Indicator: Neutral.
Additional Context
Transaction Notes
- Vesting: The reporting person acquired 23,660 shares from RSU vesting and 1,175 shares from Dividend Equivalent Units (DEUs).
- New Grants: A new award of 15,890 RSUs was granted, set to vest on March 6, 2027.
- Cost Basis: All transactions were at $0.00 per share as part of the company's 2020 Stock Incentive Plan.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.